Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$47.15 +0.18 (+0.38%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rigel Pharmaceuticals (RIGL) Selling, General & Administrative (2010 - 2026)

Updated

Rigel Pharmaceuticals' Selling, General & Administrative came in at $32.64 million for Q2 2026, up 11.6% from $29.26 million a year earlier and up 6.5% from the prior quarter.

Analysis

Rigel Pharmaceuticals (RIGL) Selling, General & Administrative (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Rigel Pharmaceuticals reported Selling, General & Administrative of $122.22 million, up 7.7% year-over-year; for FY2025, it was $115.9 million, up 2.5% from FY2024.

  • Selling, General & Administrative carries a five-year compound annual growth rate of 8.6% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $113.06 million in FY2024 (+6.9%), $105.74 million in FY2023 (-6.0%), $112.45 million in FY2022 (+22.4%) and $91.89 million in FY2021 (+20.0%).
  • The Q2 2026 figure represents the highest quarterly Selling, General & Administrative in data going back to Q2 2010.
  • Year-over-year, Selling, General & Administrative has increased for five consecutive quarters, with growth averaging 6.4% over the last eight quarters.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q3 2021 (growth of 31.3%), and the weakest in Q4 2023 (a decline of 16.5%).
  • Business Quant data shows RIGL's Selling, General & Administrative at $30.65 million (Q1 2026), $29.99 million (Q4 2025) and $28.94 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Rigel Pharmaceuticals 877.39 Mn 343.28 Mn 70.18 Mn 32.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 32.64 Mn
Mar 31, 2026 30.65 Mn
Dec 31, 2025 29.99 Mn
Sep 30, 2025 28.94 Mn
Jun 30, 2025 29.26 Mn
Mar 31, 2025 27.72 Mn
Dec 31, 2024 29.52 Mn
Sep 30, 2024 27.04 Mn
Jun 30, 2024 28.05 Mn
Mar 31, 2024 28.45 Mn
Dec 31, 2023 26.85 Mn
Sep 30, 2023 24.86 Mn
Jun 30, 2023 26.31 Mn
Mar 31, 2023 27.73 Mn
Dec 31, 2022 32.17 Mn
Sep 30, 2022 25.90 Mn
Jun 30, 2022 26.98 Mn
Mar 31, 2022 27.40 Mn
Dec 31, 2021 24.52 Mn
Sep 30, 2021 22.88 Mn
API Access

Rigel Pharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RIGL&period=max&api_key=YOUR_API_KEY